Cardio-oncologists should incorporate vascular prevention in their care, especially for those without protective hormones.

Empagliflozin reduced proinflammatory cytokines and oxidative stress markers in INOCA patients with CMD, improving vascular health. Treatment led to favorable shifts in endothelial extracellular ...

A polygenic risk score (PRS) based on genes associated with endothelial cell function identifies patients at a higher risk of coronary artery disease, according to a new study. The risk score, which ...

Researchers at Harvard Medical School have demonstrated the potent therapeutic effects of administration of the neuropeptide α-melanocyte–stimulating hormone (α-MSH) through melanocortin receptor ...

Preclinical data suggest neratinib dampens vascular inflammation and atherosclerosis by targeting ASK1 in endothelial cells, with added plaque and cytokine reductions when combined with rosuvastatin.

New Delhi: A team of German researchers has developed a new imaging technology that can noninvasively scan your skin and also ...

DelveInsight's Persistent Corneal Edema Market Insights report includes a comprehensive understanding of current treatment ...

With a new $11.3 million Program Project grant from the National Institutes of Health, experts from the Vascular Biology Center at the Medical College of Georgia at Augusta University are working to ...